Edit

Regentis Biomaterials

http://www.regentis.co.il/

Last activity: 11.02.2016

Tags:FamilyFinTechInvestmentLocalPlatformProduct

Regentis Biomaterials is a tissue repair company focused on developing and commercializing of innovative hydrogel platform for the repair of damaged tissue. The Gelrin hydrogel platform is the foundation for the company’s flagship product, GelrinC, a biodegradable implant for cartilage regeneration. The product received ISO certification and is currently undergoing clinical trials in Germany, Belgium and Israel. Regentis is funded by Crossroad Fund, Medica Venture Partners, SPCVitalife, DSM Ventures and the Technion Investment Opportunities Fund. www.regentis.co.il

Mentions

Total raised: $25M

Investors 3

Date	Name	Website
-	Crossroad	crossroad-...
-	DSM	dsm.com
-	SCP Vitali...	scpvitalif...

Funding Rounds 2

Date	Series	Amount	Investors
11.02.2016	Series D	$15M	-
14.05.2012	Series C	$10M	-

Mentions in press and media 3

Date	Title	Description	Source
11.02.2016	Regentis Biomaterials Closes $15M Series D Funding	Regentis Biomaterials Ltd., a Princeton, New Jersey and Or Akiva, Israel-based developer of cartilag...	finsmes.co...
14.05.2012	Regentis Biomaterials Announces $10M	OR AKIVA, ISRAEL, Privately held company focused on developing proprietary hydrogels for tissue re...	vcnewsdail...
14.05.2012	Regentis Biomaterials Raises $10M in Series C Funding	Regentis Biomaterials Ltd., an Or Akiva, Israel and Princeton, NJ-based company that is developing a...	finsmes.co...